Spirit Pharmaceuticals Acetaminophen Tablets Recall: Discolored Tablets Risk
Spirit Pharmaceuticals recalls 100-count acetaminophen tablets due to discoloration from manufacturing issues. Consumers should check lot numbers and contact the company for details.
Lower-risk recall
cGMP deviations: Discolored acetaminophen
Contact the company
What happened, in plain English
Spirit Pharmaceuticals is recalling 100-count acetaminophen 325 mg tablets that may have discoloration due to manufacturing deviations. This could affect product safety, though the recall does not specify a risk of serious injury. Read more at govinfonow.com/recall/36116-spirit-pharmaceuticals-acetaminophen-tablets-recall-discolored-tablets-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36116-spirit-pharmaceuticals-acetaminophen-tablets-recall-discolored-tablets-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0729-2021
Cite this page
“Spirit Pharmaceuticals Acetaminophen Tablets Recall: Discolored Tablets Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/36116-spirit-pharmaceuticals-acetaminophen-tablets-recall-discolored-tablets-risk. Based on FDA recall #D-0729-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0729-2021%22&limit=1).
Why it’s dangerous
The tablets may have discoloration due to manufacturing deviations. This could indicate a potential issue with the product's quality, but the recall does not specify a risk of serious injury or harm.
Who’s affected
People who own or use the Spirit Pharmaceuticals acetaminophen tablets with lot number S210240 (expiring 03/2023) are affected. Those with the specific product model are most at risk.
How to tell if you have this one
Check for the lot number S210240 on the bottle, which expires 03/2023. The product is a 100-count bottle of acetaminophen 325 mg tablets distributed by Walmart.
- Brand
Spirit Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number S210240 and expiration date 03/2023 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0729-2021 (June 16, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0729-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.